GlcAT Antibodies

Santa Cruz Biotechnology features a diverse variety of GlcAT monoclonal antibodies for studying Glucosyltransferases. GlcAT Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Glucosyltransferases play a central role in glycosylation processes, which are essential for protein folding, stability, and cell signaling. By modifying proteins and lipids, Glucosyltransferases influence numerous biological functions, including immune response, cell adhesion, and pathogen recognition. Understanding the activity and regulation of Glucosyltransferases is crucial for elucidating their involvement in various diseases, including cancer and metabolic disorders. Research in glycosylation pathways continues to reveal new insights into cellular processes and disease mechanisms. Investigating Glucosyltransferases can lead to breakthroughs in understanding disease progression and potential therapeutic approaches. GlcAT monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of glycosylation and its impact on human health.